within Pharmacolibrary.Drugs.ATC.J;

model J01CA03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 6 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 2000 / 1000000,
    adminCount     = 1,
    Vd             = 0.013,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Carbenicillin is a broad-spectrum, beta-lactam penicillin antibiotic historically used mainly for treatment of infections caused by Pseudomonas aeruginosa and other Gram-negative bacteria. It has been largely replaced by other agents such as ticarcillin and piperacillin, but may still be used in certain cases. Carbenicillin is not widely used today due to the availability of more effective and less toxic alternatives.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult patients, healthy volunteers, administered by intravenous bolus or infusion. Values represent typical range observed in clinical studies from mature literature.</p><h4>References</h4><ol><li><p>Meyers, BR, et al., &amp; Srulevitch, E (1980). Comparative study of piperacillin, ticarcillin, and carbenicillin pharmacokinetics. <i>Antimicrobial agents and chemotherapy</i> 17(4) 608–611. DOI:<a href=&quot;https://doi.org/10.1128/AAC.17.4.608&quot;>10.1128/AAC.17.4.608</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6446878/&quot;>https://pubmed.ncbi.nlm.nih.gov/6446878</a></p></li><li><p>Batra, VK, et al., &amp; Joy, VA (1979). Piperacillin kinetics. <i>Clinical pharmacology and therapeutics</i> 26(1) 41–53. DOI:<a href=&quot;https://doi.org/10.1002/cpt197926141&quot;>10.1002/cpt197926141</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/445961/&quot;>https://pubmed.ncbi.nlm.nih.gov/445961</a></p></li><li><p>Libke, RD, et al., &amp; Kirby, WM (1975). Ticarcillin vs carbenicillin: clinical pharmacokinetics. <i>Clinical pharmacology and therapeutics</i> 17(4) 441–446. DOI:<a href=&quot;https://doi.org/10.1002/cpt1975174441&quot;>10.1002/cpt1975174441</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1122685/&quot;>https://pubmed.ncbi.nlm.nih.gov/1122685</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01CA03;
